Mannkind (MNKD) Acquisitions (2022)

Mannkind (MNKD) posted quarterly Acquisitions of $242000.0 for Q4 2022.

Mannkind (MNKD) Acquisitions (2022) Analysis & Trends

Mannkind (MNKD) has reported Acquisitions for 1 consecutive years, with $242000.0 the latest figure, recorded in Q4 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn -
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn -
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -
7 Royalty Pharma 33.72 Bn 35.84 Bn - -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn -
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -
10 Mannkind 1.19 Bn 1.08 Bn 94.97 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2022 242,000.00